FI
AGIO icon

Fosun International’s Agios Pharmaceuticals AGIO Stock Holding History

Fosun International’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,652
Closed -$3.06M – 231
2019
Q2 		$3.06M Buy
+61,652
New +$3.3M 0.2% 77

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fosun International's AGIO Position: Q3 2019 in Review

Fosun International sold out of Agios Pharmaceuticals (AGIO) in Q3 2019, closing a stake of 61,652 shares — an estimated $3.06M sold.

Fosun International first reported a position in AGIO in Q2 2019 and held it in 1 quarter. The position peaked at $3.06M in Q2 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

  • Fosun International reported no remaining Agios Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 61,652 Agios Pharmaceuticals shares in Q3 2019, an estimated $3.06M.
  • Fosun International first reported a position in Agios Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Fosun International's Agios Pharmaceuticals position peaked at $3.06M in Q2 2019.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.